Metraipolis › archive › dc_60c75763dca3
Pharmacological interventions for obesity in patients with inflammatory bowel disease: A systematic review of GLP-1 receptor agonist efficacy and safety — Europe PMC PMID:42095067
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42095067
- DOI
- 10.1016/j.obpill.2026.100272
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T01:09:38.659Z
- SHA-256 of the archived text
e72fb39ec15be35a8129229d323918785eca71d8882dce9120161d028cbb293c- Stable URL of this page
https://metraipolis.com/documento/dc_60c75763dca3
How to cite
Pharmacological interventions for obesity in patients with inflammatory bowel disease: A systematic review of GLP-1 receptor agonist efficacy and safety — Europe PMC PMID:42095067 — Europe PMC (en), https://europepmc.org/article/MED/42095067 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_60c75763dca3 (Metraipolis archive dc_60c75763dca3, sha256 e72fb39ec15be35a8129229d323918785eca71d8882dce9120161d028cbb293c)
BibTeX
@misc{dc60c75763dca3,
title = {Pharmacological interventions for obesity in patients with inflammatory bowel disease: A systematic review of GLP-1 receptor agonist efficacy and safety — Europe PMC PMID:42095067},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42095067},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_60c75763dca3; sha256 e72fb39ec15be35a8129229d323918785eca71d8882dce9120161d028cbb293c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42095067. Agents can read the archived copy with the MCP tool read_document.